eFFECTOR Therapeutics Inc (EFTR) has fallen 3.88% Thursday In Premarket Trading

eFFECTOR Therapeutics Inc (EFTR) is down Thursday morning, with the stock falling -3.88% in pre-market trading to 1.24. EFTR's short-term technical score of 97 indicates that the stock has traded more bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, which ranks 71 out of 146 industries, the stock ranks higher than 95% of stocks. eFFECTOR Therapeutics Inc has risen 138.89% over the past month, closing at $0.54 on May 11. During this period of time, the stock fell as low as $0.53 and as high as $1.48. EFTR has an average analyst recommendation of Strong Buy. The company has an average price target of $6.25.

EFTR has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on EFTR!

See Full EFTR Report

eFFECTOR Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 79 by this metric, EFTR ranks better than 79% of stocks.

Important Dates for Investors in EFTR:

-eFFECTOR Therapeutics Inc is set to release earnings on 8/7/2023. Over the last 12 months, the company has reported EPS of $-0.86. -We do not have a set dividend date for eFFECTOR Therapeutics Inc at this time. Click Here To Get The Full Report on eFFECTOR Therapeutics Inc (EFTR)